Correlation Between Alnylam Pharmaceuticals and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and PDS Biotechnology Corp, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and PDS Biotechnology.
Diversification Opportunities for Alnylam Pharmaceuticals and PDS Biotechnology
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Alnylam and PDS is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and PDS Biotechnology
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 0.54 times more return on investment than PDS Biotechnology. However, Alnylam Pharmaceuticals is 1.85 times less risky than PDS Biotechnology. It trades about -0.19 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.31 per unit of risk. If you would invest 28,691 in Alnylam Pharmaceuticals on August 28, 2024 and sell it today you would lose (3,593) from holding Alnylam Pharmaceuticals or give up 12.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| PDS Biotechnology Corp |
Alnylam Pharmaceuticals and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and PDS Biotechnology
The main advantage of trading using opposite Alnylam Pharmaceuticals and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |